Skip to main content
Table of Contents
Print

What Are Common Misconceptions About Cannabis Use in EDS Patients? 

Author: Dr. Clarissa Morton, PharmD

Despite the growing interest in cannabis as a treatment for Ehlers-Danlos Syndrome (EDS) , there are still several cannabis myths EDS patients encounter. These misconceptions can create barriers for those considering cannabis as a potential solution for managing pain, inflammation, and other symptoms. 

Common Cannabis Myths EDS Patients Face 

  • Cannabis is a Last Resort or “Alternative” Treatment: 
    Many people still view cannabis as a treatment of last resort, often overlooking its potential effectiveness in managing symptoms. However, for many EDS patients, cannabis has proven to be a reliable option for symptom relief and is seen as a valuable part of a broader treatment plan. 
  • Cannabis is Addictive or Dangerous: 
    The cannabis stigma continues to be a major issue, with some believing that cannabis use can lead to addiction or other harmful side effects. However, many EDS patients report that cannabis helps them manage chronic pain and improve mobility without the adverse effects often associated with pharmaceutical options like opioids. 
  • It Doesn’t Provide Real Medical Benefits: 
    EDS myths often include the notion that cannabis doesn’t offer significant medical benefits or that its effects are purely psychological. In reality, research shows that cannabis, particularly CBD, can help reduce inflammation, manage pain, and improve quality of life for EDS patients. 

The Need for Greater Public Awareness 

The public awareness of the medicinal benefits of cannabis remains limited, particularly for conditions like EDS. Increased education and dialogue around its role in symptom management can help break down these misconceptions and ensure that more patients are aware of its potential. 

If you’re considering cannabis for EDS treatment, consulting with a healthcare professional can help you navigate these myths and make informed decisions.  

Visit providers like LeafEase for personalised consultations focused on your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to medical cannabis and Ehlers-Danlos Syndrome.

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories